Competing interests
Blindness
EYE, BLINDNESS
R.E.M. and M.D.F. have received grant support, clinical trial support and consultancy fees from Biogen. R.E.M. is a named inventor on the BIIB111 patent licensed by the University of Oxford. B.L.L. has received grant support and consultancy fees from Biogen. E.-M.K.S. has received clinical trial support from Biogen. A.G. was an employee of Nightstar at the time of the study. J.A.G., S.P., D.Y. and G.Z. were employees of Biogen at the time of the study and may hold stock in the company. M.E.P. has received consultancy fees from Biogen and grant funding from Research to Prevent Blindness (New York) to Casey Eye Institute (unrestricted grant).